The canonical Wnt/b-catenin signaling pathway plays a crucial role in the maintenance of the balance between proliferation and differentiation throughout embryogenesis and tissue homeostasis. b-Catenin, encoded by the Ctnnb1 gene, mediates an intracellular signaling cascade activated by Wnt. It also plays an important role in the maintenance of various types of stem cells including adult stem cells and cancer stem cells. However, it is unclear if b-catenin is required for the derivation of mouse embryo-derived stem cells. Here, we established b-catenin-deficient (b-cat D/D ) mouse embryo-derived stem cells and showed that b-catenin is not essential for acquiring self-renewal potential in the derivation of mouse embryonic stem cells (ESCs). However, teratomas formed from embryo-derived b-cat D/D ESCs were immature germ cell tumors without multilineage differentiated cell types. Re-expression of functional b-catenin eliminated their neoplastic, transformed phenotype and restored pluripotency, thereby rescuing the mutant ESCs. Our findings demonstrate that b-catenin has pleiotropic effects in ESCs; it is required for the differentiation of ESCs and prevents them from acquiring tumorigenic character. These results highlight b-catenin as the gatekeeper in differentiation and tumorigenesis in ESCs.
Introduction
The Wnt/b-catenin signaling pathway is an evolutionarily conserved signal transduction cascade and functions during early development to regulate body axis specification, germ layer formation and organogenesis [1] . It is not surprising that mutations of the Wnt pathway components are associated with many hereditary disorders, cancer, and other diseases [2] . In preimplantation embryo development, fertilized oocytes go through a series of cleavage divisions which lead to blastocyst formation. The body axes and germ layers in mammalian embryos are established after implantation and Wnt/b-catenin signaling plays an important role in the establishment of the basic body plan in mouse embryos [1] . Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of the mammalian blastocyst and are capable of proliferating indefinitely in culture while maintaining an undifferentiated pluripotent state [3, 4] . Wnt/b-Catenin signaling has a dominant role in the in vitro maintenance of both mouse and human ESCs [5] . However, it is unclear how the known function of Wnt signaling in early embryonic development relates to its regulation of pluripotency and lineage decisions in pluripotent stem cells.
b-Catenin is an essential component of the Wnt/b-catenin signaling pathway. In the absence of a Wnt signal, b-catenin is rapidly degraded by a multi-protein complex including Axin, adenomatous polyposis coli (APC) and glycogen synthase kinase 3 (GSK3). Wnt proteins stimulate signaling through various frizzled receptors, low density lipoprotein receptor-related protein 5/6 (LRP 5/6) co-receptors and disheveled to inactivate the b-catenindegradation complex, and the stabilized b-catenin associates with transcription factors of the Tcf (T-cell factor)/Lef (lymphoid enhancer factor) family resulting in the transcriptional activation of target genes [1, 5] .
Previous studies based on both loss-and gain-of-function mutations of b-catenin in mice have established the importance of the role of Wnt/b-catenin signaling in the regulation of the vertebral axis, germ layer specification and tumorigenesis [6] . Elegant studies have genetically demonstrated that b-catenin is indispensable for differentiation, but it is not required for selfrenewal of mouse ESCs [7, 8] . The Ctnnb1 deficient mouse ESC lines were established by deleting functional exons in cultured mouse ESC lines, and it still remains to be determined whether bcatenin plays an important role in the transformation of preimplantation embryos into pluripotent stem cells.
Our recent work demonstrated that b-catenin plays a role in sperm-oocyte membrane adhesion and the transition of the membrane upon mouse fertilization, using homogenous defects of b-catenin in both oocyte and sperm cells [9] . Here, we report the generation of novel Ctnnb1-deficient mouse embryo-derived stem cells (b-cat D/D mESCs) with the deletion of exons 2-6 using mice containing the loss-of-function mutation in b-catenin to produce mutant oocyte and sperm through the germ cell-specific Cre-loxP system. b-cat D/D mESCs are a material which can be used to address the role of b-catenin in the acquisition of pluripotency including self-renewal and differentiation from preimplantation embryos. It is also noteworthy that b-cat D/D mESCs lack the residual b-catenin of either maternal or paternal origin. Our results show that b-catenin is not essential for acquiring and maintaining proliferative self-renewal, but that it is required for normal multilineage differentiation. Interestingly, these embryo-derived b-cat D/D mESCs contributed to oncogenic germ cell tumors in a teratoma assay. These results were corroborated by our rescued b-cat D/D mESCs experiments. Our findings show that b-catenin plays an important role in multilineage differentiation and tumorigenesis in germ cell tumors. Our embryo-derived b-cat D/D mESCs also provide a novel research tool for immature germ cell tumors.
Materials and Methods

Generation of Completely b-catenin-deficient Embryos
To produce oocytes with a single gene deleted, floxed mutant mice on a C57BL/6J background with exon 2-6 flanked by loxP on the b-catenin gene (Ctnnb1) [10] were crossed with transgenic (Tg) mice on a C57BL/6J background expressing cre-recombinase in an oocyte-specific manner under the control of oocyte-specific zona pellucida glycoprotein 3 (ZP3) promoter (Tg ZP32cre ), which was kindly provided by Dr. Barbara B. Knowles (the Jackson Laboratory, ME, USA). The F1 offspring, b-catenin
, were propagated through brother-sister mating. The presence of the cre-recombinase gene in these offspring was detected by polymerase chain reaction (PCR) analysis using the following set of primers: Cre-S [tgatgaggttcgcaagaacc; nucleotide no. 170 to 189 (GenBank Accession no. AB449974.1)] and Cre-A [ccatgagtgaacgaacctgg; nucleotide no. 539 to 558 (GenBank Accession no. AB449974.1)]. This primer set yielded a band of 389 bp. Furthermore, to produce conditionally b-catenin-deficient sperm, b-catenin floxed/floxed (b-cat fl/fl ) mice were mated with mice expressing cre-recombinase driven by protamine promoter [11] , which was kindly provided by Dr. Masaru Okabe (Osaka University, Japan). We produced b-catenin floxed/floxed Tg protamin2cre male mice, and confirmed that the b-catenin gene was deleted in their epididymal sperm (data not shown). Then, to obtain completely b-catenin-deficient embryos, these two strains of mice were crossed. The b-catenin-deficient (b-cat D/D ) fertilized eggs were collected and cultured to the blastocyst stage at 37uC and 5% CO 2 in air.
Mouse ESC Establishment and Cell Culture
Embryo-derived stem cells were established using mouse ESCs derivation medium of knockout DMEM (Life Technologies, CA, USA) supplemented with 15% knockout serum replacement, 1 x non-essential amino acids (NEAA), 0.05 mM 2-mercaptoethanol, 2 mM GlutaMax, 100 U/mL penicillin G, 10 mg/mL streptomycin (all from Life Technologies), 1000 U/mL of leukemia inhibitory factor (LIF) (Wako, Japan) and the MEK kinase inhibitor PD98059 (Cell Signaling Technology, Danvers, MA). The blastocyst embryos developed from b-catenin-deficient fertilized eggs were individually treated with EmbryoMax Acidic Tyrode's Solution (Merck Millipore, Germany) to remove the zona pellucidae and plated on a feeder layer. Mouse embryonic fibroblasts (MEF) were inactivated by gamma irradiation in gelatinized culture dishes with mouse ESCs derivation medium. At 48 hours after plating, one half volume of fresh medium was added to each culture well. The medium was changed daily and inner cell mass-derived outgrowths were dislodged with a Pasteur pipette, washed in a drop of fresh mouse ESC derivation medium and incubated for 5 min in StemPro Accutase (Life Technologies) at 37uC. The clumps were gently dissociated with a Pasteur pipette and transferred onto a fresh plate of MEF [12] . b-cat D/D mESCs were maintained in mESC medium which was composed of derivation medium without PD98059. b-cat D/D mESCs were continuously passaged every 2-3 days with 5-to 10-fold dilution by Accutase digestion. For serum-free and feeder-free cultures, mESCs were cultured in N2 and B27 medium (Life Technologies) supplemented with 1,000 U/ml LIF, 3 mM CHIR99021 (Wako) and 1 mM PD0325901 (Wako) on Matrigel-coated (BD Biosciences, San Jose, CA) dishes [13, 14] To detect different combinations of fl/fl, fl/D and D/D bcatenin alleles, the genomic PCR was performed using the following primer: (aaggtagagtgatgaaagttgtt, caccatgtcctctgtctattc and tacactattgaatcacagggactt). The resulting products of 221, 324 and 500 bp corresponded to the wild-type allele, the floxed allele and the deleted allele, respectively [9, 10] .
Differentiation Assays in vitro and in vivo
For induction of differentiation in vitro, 1610 4 feeder-independent mESCs were plated onto each well of 96-well plate with a low attachment surface (Lipidure; NOF corporation, Japan) and cultured in differentiation medium containing Knockout DMEM (Life technologies) with 20% FBS (Hyclone, Thermo Fisher Scientific), 16NEAA, 2 mM GlutaMax, 100 U/mL penicillin G and 10 mg/mL streptomycin (all from Life Technologies), to generate embryoid bodies (EBs).
For the tumor formation assay, NCH4. 6 cells/ml in mESC medium, and 200 ml of the cell suspension (1610 6 cells) were injected subcutaneously into the dorsal flank of nude mice (Clea Japan, Japan) using a 25-G needle. Three to four weeks after injection, tumors were surgically dissected from the mice. Samples were fixed in phosphate-buffered saline (PBS) containing 4% formaldehyde and embedded in paraffin and subjected to histological examination with hematoxylin and eosin (HE) staining. Small samples of the tissue samples were also collected for RNA isolation.
Construction of b-catenin Constitutively Expression Plasmid
The b-catenin expression vector was constructed as follows. The mCherry was amplified by PCR with primer pairs 59-BstBImCherry (ttcgaaatggtgagcaagggcgagga) and mCherry-Bam-39 (ggatccttacttgtacagctcgtcca) to add BstBI and BamHI sites to the 59-and 39-sites of mCherry (Takara Bio, Japan), and cloned into pCR2.1-TOPO vector (Life Technologies), to create TOPOmCherry. This mCherry fragment was excised from TOPOmCherry by BstBI and BamHI digestion, and inserted into the 
Karyotypic Analysis
Chromosome karyotyping was carried out at the Nihon Gene Research Laboratories, Miyagi, Japan).
Alkaline Phosphatase Staining and Immunocytochemistry
Alkaline phosphatase (ALP) staining for mouse ESCs was carried out using an alkaline phosphatase kit (Dako, Denmark) according to the manufacturer's protocol. Immunohistochemistry was carried out on mouse ESCs or EBs seeded on gelatin covered 35 mm glass coverslips (IWAKI, Japan) after fixation with 4% paraformaldehyde, followed by permeabilization in PBS with 0.5% Triton-X and blocking with PBS containing 5% normal serum appropriate for each antibody. Incubation with primary antibodies against Oct3/4 (sc-5792; Santa Cruz Biotechnology, Ca), Nanog (rcab0001P; ReproCell, Japan), Sox2 (ab5603; Merck Millipore, Germany), E-cadherin (M108; Takara Bio), b-catenin (C7207; Sigma-Aldrich, MO), a-catenin (C2081; Sigma-Aldrich), Tuj-1 (G7121;Promegam, WI), Desmin (D1033; Sigma-Aldrich), Afp (MAB1368; R&D Systems, MN) and Plakoglobin (610253; BD Biosciences) was carried out overnight at 4uC. Incubation with corresponding secondary anti-mouse, anti-rabbit and anti-goat antibodies coupled with Alexa 488 or Alexa 546 (BD Biosciences) containing 49,6-diamidino-2-phenylindole (DAPI) for nuclei staining was carried out for one hour at room temperature in the dark in PBS containing 0.1% bovine serum albumin. Staining was observed under a LSM 720 laser scanning confocal microscope.
Tumor samples were fixed in PBS containing 4% formaldehyde and embedded in paraffin. Sections were stained with the following primary antibodies: anti-keratin5/8 (sc-70928; Santa Cruz Biotechnology), Desmin (D1033; Sigma-Aldrich), NeuN (MAB377; Merck Millipore), Oct3/4 (sc-5279; Santa Cruz Biotechnology), pan-Cytokeratin (cytokeratin 5, 6 and 8) (ab6401; abcam, UK), Sall4 (H00057167 1:100; Abnova, Taiwan), b-catenin (C7207; Sigma-Aldrich).
Quantitative RT-PCR Analyses and Genotyping
RNA was isolated using the RNeasy Mini Kit (QIAGEN, Germany). Single strand complementary DNA was synthesized from 1-2 mg of total RNA in 20 ml of reaction mixture containing oligo-dT or random primers using the Superscript III first strand cDNA synthesis system (Life Technologies). We used two types of chemistries for the quantitative reverse transcription polymerase chain reaction (qRT-PCR); TaqMan probe-based [TaqMan Array Mouse Stem Cell Pluripotency Panel (P/N 4385363): Life Technologies] and SYBR Green-based (Platinum SYBR Green qPCR SuperMix-UDG: Life Technologies) systems. Transcript levels were determined using the ABI PRISM Sequence Detection System 7900HT (Life Technologies). All qRT-PCRs using SYBR Green were carried out in triplicate, and relative quantification was carried out using Gapdh as a reference gene. Actb, Gapdh and Eef1a1 were used as endogenous controls when we analyzed gene expression using the TaqMan Array. Hierarchical clustering analyses were performed using Ct values for gene expression data with MEV v4.8 statistical analysis software. The primers used were as follow: Oct3/4, F tgttcccgtcactgctctgg and R ttgccttggctcacagcatc; Nanog, F cctgattcttctaccagtccca and R ggcctgagagaacacagtcc; Lefty1, F gctacaacacagccatgcca and R cctcttttgcctccggagag; Afp, F ccatcacctttacccagtttgt and R cccatcgccagagtttttctt; T, F ctcggattcacatcgtgagag and R aaggctttagcaaatgggttgta; NeuroD1, F acagacgctctgcaaaggttt and R ggactggtaggagtagggatg; Ctnnb1, F ctcaccaccgcgagggcttg and R gcagtccaccagctaggcgc; Tcf3, F gacagaagtggaatttgtgtccg and R agtgcctgctactttctacgat; Sox2, F gcggagtggaaacttttgtcc and R cgggaagcgtgtacttatcctt; Klf4, F aacctttcacactgtcttcccacg and R cccttggactcttcctttctcctg; Axin2, F gcaggagcctcacccttc and R tgccagtttctttggctctt; Sox17, F agccatttcctccgtggtgt and R aacactgcttctggccctcag; Nestin, F tgcatttccttgggataccag and R cttcagaaaggctgtcacaggag; Gapdh, F tgcgacttcaacagcaactc and R cttgctcagtgtccttgctg.
Western Blot Analysis
Western blots were carried out as described by Ishii et al. with slight modification [18] . Western blots were carried out using the following antibodies: b-catenin (C-7738; Sigma-Aldrich), Oct3/4 (sc-5279; Santa Cruz Biotechnology), Nanog (REC-RCAB0002PF; ReproCell) and b-actin (F3777; Sigma-Aldrich). D/D mESCs were injected into blastocysts of ICR mice, then transferred to the uteri of pseudopregnant ICR mice, as described previously [15, 20] . Res-b-cat D/D mESCs with mCherry fluorescence were used for blastocyst injections as donor cells. Embryos were dissected either on embryonic day (E) 10.5 or 12.5 and the contribution of mESCs to embryos was assessed using a fluorescence stereomicroscope (MVX10, OLYMPUS, Japan).
Blastocyst Injections to Produce Chimeras
Animal Studies
All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of the National Research Institute for Child Health and Development (NRICHD, Permit Number: A2006-009). Mice were housed in plastic cages lined with soft wood chips. The cages were kept in a conventional, air-conditioned mouse room under a 12 h light/ dark cycle and the mice received food and water ad libitum. All the transgenic mice were monitored for signs of suffering including tumor formation and weakening at least every two days. All surgery was performed under isoflurane anesthesia. Mice were euthanized by carbon dioxide inhalation at humane endpoints or before the collection of embryos and tissue samples as recommended by the American Veterinary Medical Association Panel on Euthanasia. All experiments were subject to the 3 R consideration (refine, reduce and replace) and all efforts were made to minimize animal suffering, and to reduce the number of animals used.
Results
Characterization of b-catenin Deficient Mouse Embryoderived Stem Cells
We have previously reported the role of b-catenin in spermoocyte adhesion using transgenic mice containing oocyte-and sperm-specific cre-recombinase [9] . Using these mouse models, we produced b-catenin-deficient blastocysts by collecting two-cell embryos and developing them in vitro. The success rate for achieving blastocyst development was around 80%. We estab- (Figure 4 ). While the well-characterized human germ cell tumors allows identification for histologic classification [24] , to date, no animal model is available for analyzing testicular GCT formation and progression [25] . ''Seminoma'' lesions in bcat D/D tumors were histologically characterized by a composition of tubular structures lined by seminoma cells with clear cytoplasm, and well-defined cytoplasmic borders, central to marginally located nuclei. These gross appearances were similar to that of classic seminoma in humans in that they had a ''fried-egg'' appearance ( Figure 4 [26] . To classify GCTs, immunomarkers are vital. Pluripotent stem cell markers such as OCT3/4, NANOG, and SALL4 are used in clinical trials as they are very sensitive and specific markers [26, 27, 28] . In our immunohistochemical analysis using specific markers of GCTs, pan-Cytokeratin (AE1/AE3) were focally positive in ''EC'' lesions and strongly positive in ''choriocarcinoma'' areas of the b-cat D/D tumors, but not expressed in the ''seminoma'' areas. OCT3/4 is one of the most robust diagnostic markers of human testicular GCTs [25] . ''Seminomas'' and ''ECs'' lesions showed strong positive nuclear staining for Oct3/4, but ''choriocarcinoma'' cells were negative. SALL4 has been reported to be expressed in subtypes of GCT with high sensitivity and specificity [28, 29] . ''Seminoma'' and ''EC'' lesions showed positive staining, but ''choriocarcinoma'' areas of the b-cat D/D tumors were negative. Notably, in all attempts, b-cat D/D mESC lines generated tumors with a carcinomatous appearance, whereas wild-type counterparts gave rise to teratomas with normal differentiation patterns ( Figure 5 ).
We sought to confirm our findings by qRT-PCR for pluripotent markers. Quantitative RT-PCR analysis was performed independently more than three times for each sample. b-cat D/D tumors expressed oct3/4, nanog and lefty1 at high levels ( Figure 6A teratomas ( Figure 6B ). Additionally, western blot analysis showed that Nanog and Oct3/4 were detected at the protein level in bcat D/D tumors, while they were undetected in teratomas generated from b-cat fl/fl mESC lines ( Figure 6C ). In the clinical diagnosis of GCTs, most yolk sac tumors produce AFP, but classic seminomas, pure ECs and choriocarcinomas do not [30] 
Discussion
Multicellular organisms require stem cells and precise control of them to maintain tissue homeostasis, the replacement of terminally differentiated, aged or damaged cells [31] . Loss of stem cell activity and tissue homeostasis is likely linked to the emergence of diseases including cancer [32, 33] . There is considerable interest in finding ways of perpetuating the pluripotency of embryo-derived cells, and gaining this knowledge is of vital importance for many potential biomedical applications related to tissue engineering and disease modeling [31, 34] . ESCs are one of the most characterized embryo-derived pluripotent stem cells and Wnt/b-catenin signaling has been implicated in their maintenance for both mouse and human [35, 36] . The ICM of the blastocyst delaminates giving rise to a primitive ectoderm and a primitive endoderm layer, and further differentiated cells progressively lose their differentiation potential. ESCs can be derived from the pluripotent ICM of blastocysts. In addition, b-catenin does not play a crucial role during preimplantation development [37] , and at the implantation stage, inactivation of the canonical Wnt/b-catenin signaling pathway blocks blastocyst competency for implantation [38] . It remains unclear whether this signaling is crucial for the acquisition of pluripotency from the ICM of b-catenin-deficient preimplantation embryos. Previous studies failed to eliminate the effects of remnant bcatenin of maternal or paternal origin. Our conditional mutagenesis studies of b-catenin excluded remnant b-catenin in sperm and eggs, demonstrating that b-catenin is dispensable for fertilized eggs. Furthermore, b-catenin is not required for the acquisition of self-renewal potential by embryo-derived stem cells. However, bcatenin is an indispensable prerequisite for pluripotency. Embryos lacking functional b-catenin activity show a development loss following implantation at around E7.0 with defects in anteriorposterior patterning and mesoderm and definitive endoderm formation [9, 21, 22] . The role of b-catenin in early development remained to be elucidated because embryonic lethality is associated with the loss-of-function mutation. We observed that the in vitro differentiation of embryo-derived b-cat D/D mESCs is impaired similarly to b-catenin-mutant embryos [21, 22] . bCatenin-defect mESCs contribute to chimeric embryos, but the contribution ratio is quite low compared to control mESCs [7] . Previous experiments made observations at earlier times of pregnancy (E7.0 to E8.5). In contrast, our chimeric embryo studies were analyzed on E12.5 and no chimeric compartments were detected. This may have been due to the progressive loss of contribution of b-catenin-defective cells. In other words, b-catenin is required for cellular differentiation and/or viability in early embryogenesis up to E12.5. Notably, the defects of b-cat D/D mESCs in differentiation in vitro and in vivo could be rescued by reintroducing functional b-catenin. Thus, b-catenin is a caretaker in both in vitro ESC differentiation and in vivo cellular differentiation during development.
Implicating Loss-of-function Mutation in b-catenin in Testicular Germ Cell Tumorigenesis
The central player in the canonical Wnt cascade is b-catenin, a cytoplasmic protein whose stability is regulated by the destruction complex. The tumor suppressor protein, Axin acts as the scaffold of this complex as it directly interacts with all other components including b-catenin, the tumor suppressor protein, APC, and the two kinase families CK1 and GSK3 [39] . Deregulated Wnt/bcatenin signaling is associated with many human diseases, including cancer, osteoporosis, aging and degenerative disorders [39, 40, 41] . Constitutive b-catenin signaling, resulting from deficiency of the destruction complex or oncogenic b-catenin mutations that prevent its degradation, leads to excessive stem cell renewal/proliferation that predisposes cells to tumorigenesis [2, 42] . Previously, two groups of researchers independently showed that APC mutant and GSK3a/b double-mutant mESCs remain undifferentiated and possess a malignant phenotype in the teratoma assay [43, 44] . APC-mutant mESCs generated undifferentiated carcinomatous tumors with raised levels of b-catenin [43] , while GSK3a/b double-mutant mESCs generated grossly undifferentiated carcinomatous tumors with bone tissues as the only differentiated structures [44] . The mechanisms underlying the oncogenesis of both the APC-mutant and GSK3a/b doublemutant mESCs is unclear. Our b-catenin loss-of-function mESCs displayed a tumorigenic phenotype with the carcinomatous appearance of mixed germ cell tumors in a teratoma assay. The tumors derived from our embryo-derived b-cat D/D mESCs included a mixture of classic seminomas, embryonal carcinomas and choriocarcinomas, identifications we made based on the histological features of human carcinomas [24, 26] Human germ cell tumors are a heterogeneous type of neoplasm, mostly originate from germ cells [27] . The characteristics of germ cell tumors are either derived from the process of tumorigenesis or a reflection of normal embryonal development, a feature which contributes to the complexity of these tumors [25] . Embryoderived pluripotent stem cells allow a better understanding of the biology of GCTs.
Our results reveal that b-catenin signaling guides healthy development and normal cellular differentiation, and disruption of b-catenin signaling initiates oncogenicity turning embryo-derived stem cells into mixed germ cell tumors. The re-introduction of bcatenin expression can rescue the normal pluripotency, highlighting potential clinical approaches for clinical treatments of mixed germ cell tumors. There is currently no animal model of testicular mixed germ cell tumors [25] . Therefore, b-cat D/D mESCs are novel research tools for the study of tumorigenesis of testicular germ cell tumors and the function of b-catenin in cell-fate switching between tissue homeostasis and oncogenesis. 
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